{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T14:27:44Z","timestamp":1787063264297,"version":"build-2736575974"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,5]],"date-time":"2024-10-05T00:00:00Z","timestamp":1728086400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["22K07528"],"award-info":[{"award-number":["22K07528"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["23K07095"],"award-info":[{"award-number":["23K07095"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.bbrc.2024.150770","type":"journal-article","created":{"date-parts":[[2024,9,30]],"date-time":"2024-09-30T13:13:59Z","timestamp":1727702039000},"page":"150770","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Arginine: A potential prophylactic supplement for transthyretin amyloidosis"],"prefix":"10.1016","volume":"737","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-2909-6726","authenticated-orcid":false,"given":"Atsushi","family":"Fukunari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2899-5313","authenticated-orcid":false,"given":"Hiroaki","family":"Matsushita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamon","family":"Furukawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haruya","family":"Matsuzaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiromitsu","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukiko","family":"Ogawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuke","family":"Sugimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumika","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6814-0582","authenticated-orcid":false,"given":"Mitsuharu","family":"Ueda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7115-9105","authenticated-orcid":false,"given":"Yukio","family":"Ando","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2024.150770_bib1","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1080\/13506129.2020.1835263","article-title":"Amyloid nomenclature 2020: update and recommendations by the International Society of Amyloidosis (ISA) nomenclature committee","volume":"27","author":"Benson","year":"2020","journal-title":"Amyloid"},{"key":"10.1016\/j.bbrc.2024.150770_bib2","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1080\/13506129.2022.2147636","article-title":"Amyloid nomenclature 2022: update, novel proteins, and recommendations by the international society of amyloidosis (ISA) nomenclature committee","volume":"29","author":"Buxbaum","year":"2022","journal-title":"Amyloid"},{"key":"10.1016\/j.bbrc.2024.150770_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuint.2022.105313","article-title":"Transthyretin: its function and amyloid formation","volume":"155","author":"Ueda","year":"2022","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.bbrc.2024.150770_bib4","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1080\/13506129.2022.2052838","article-title":"Guidelines and new directions in the therapy and monitoring of ATTRv amyloidosis","volume":"29","author":"Ando","year":"2022","journal-title":"Amyloid"},{"key":"10.1016\/j.bbrc.2024.150770_bib5","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1038\/modpathol.2011.117","article-title":"Clinicopathological features of senile systemic amyloidosis: an ante- and post-mortem study","volume":"24","author":"Ueda","year":"2011","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.bbrc.2024.150770_bib6","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1126\/science.321.5897.1764","article-title":"Aging. Searching for the secrets of the super old","volume":"321","author":"Leslie","year":"2008","journal-title":"Science"},{"key":"10.1016\/j.bbrc.2024.150770_bib7","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s13023-017-0726-x","article-title":"Diagnosis and management of transthyretin familial amyloid polyneuropathy in Japan: red-flag symptom clusters and treatment algorithm","volume":"13","author":"Sekijima","year":"2018","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.bbrc.2024.150770_bib8","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1002\/mus.26034","article-title":"Estimating the global prevalence of transthyretin familial amyloid polyneuropathy","volume":"57","author":"Schmidt","year":"2018","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.bbrc.2024.150770_bib9","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1186\/s13023-023-02910-3","article-title":"Optimal practices for the management of hereditary transthyretin amyloidosis: real-world experience from Japan, Brazil, and Portugal","volume":"18","author":"Ando","year":"2023","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.bbrc.2024.150770_bib10","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/s41582-019-0210-4","article-title":"Hereditary transthyretin amyloidosis: a model of medical progress for a fatal disease","volume":"15","author":"Adams","year":"2019","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.bbrc.2024.150770_bib11","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1136\/jnnp-2014-308724","article-title":"Transthyretin (ATTR) amyloidosis: clinical spectrum, molecular pathogenesis and disease-modifying treatments","volume":"86","author":"Sekijima","year":"2015","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.bbrc.2024.150770_bib12","first-page":"265","article-title":"Effects of arginine in therapeutic protein formulations: a decade review and perspectives","volume":"6","author":"Ren","year":"2023","journal-title":"Antib. Ther."},{"key":"10.1016\/j.bbrc.2024.150770_bib13","doi-asserted-by":"crossref","first-page":"197","DOI":"10.4161\/pri.28938","article-title":"The therapeutic potential of chemical chaperones in protein folding diseases","volume":"8","author":"Cortez","year":"2014","journal-title":"Prion"},{"key":"10.1016\/j.bbrc.2024.150770_bib14","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1093\/hmg\/ddm311","article-title":"Soluble polyglutamine oligomers formed prior to inclusion body formation are cytotoxic","volume":"17","author":"Takahashi","year":"2008","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbrc.2024.150770_bib15","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1093\/hmg\/ddg144","article-title":"Prevention of polyglutamine oligomerization and neurodegeneration by the peptide inhibitor QBP1 in Drosophila","volume":"12","author":"Nagai","year":"2003","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbrc.2024.150770_bib16","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1093\/brain\/awaa115","article-title":"Arginine is a disease modifier for polyQ disease models that stabilizes polyQ protein conformation","volume":"143","author":"Minakawa","year":"2020","journal-title":"Brain"},{"key":"10.1016\/j.bbrc.2024.150770_bib17","doi-asserted-by":"crossref","first-page":"11259","DOI":"10.1074\/jbc.RA119.007851","article-title":"A cell-based high-throughput screening method to directly examine transthyretin amyloid fibril formation at neutral pH","volume":"294","author":"Ueda","year":"2019","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbrc.2024.150770_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2021.e08101","article-title":"Glavonoid, a possible supplement for prevention of ATTR amyloidosis","volume":"7","author":"Matsushita","year":"2021","journal-title":"Heliyon"},{"key":"10.1016\/j.bbrc.2024.150770_bib19","article-title":"Amyloid fibril formation is suppressed in microgravity","volume":"25","author":"Matsushita","year":"2021","journal-title":"Biochem Biophys Rep"},{"key":"10.1016\/j.bbrc.2024.150770_bib20","article-title":"Suppression of amyloid fibril formation by UV irradiation","volume":"15","author":"Matsushita","year":"2022","journal-title":"J. Radiat. Res. Appl. Sci."},{"key":"10.1016\/j.bbrc.2024.150770_bib21","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0001176","article-title":"Inhibition of protein aggregation: supramolecular assemblies of arginine hold the key","volume":"2","author":"Das","year":"2007","journal-title":"PLoS One"},{"key":"10.1016\/j.bbrc.2024.150770_bib22","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1002\/btpr.1766","article-title":"Interactions between L-arginine\/L-arginine derivatives and lysozyme and implications to their inhibition effects on protein aggregation","volume":"29","author":"Gao","year":"2013","journal-title":"Biotechnol. Prog."},{"key":"10.1016\/j.bbrc.2024.150770_bib23","doi-asserted-by":"crossref","first-page":"5481","DOI":"10.1038\/s41598-018-23718-3","article-title":"Small molecules attenuate the interplay between conformational fluctuations, early oligomerization and amyloidosis of alpha synuclein","volume":"8","author":"Ghosh","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbrc.2024.150770_bib24","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1021\/bp0498793","article-title":"Role of arginine in protein refolding, solubilization, and purification","volume":"20","author":"Tsumoto","year":"2004","journal-title":"Biotechnol. Prog."},{"key":"10.1016\/j.bbrc.2024.150770_bib25","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1093\/jn\/120.12.1610","article-title":"Failure of tryptophan deficiency to reduce specifically serum levels of transthyretin or albumin in rats","volume":"120","author":"Bleiberg-Daniel","year":"1990","journal-title":"J. Nutr."},{"key":"10.1016\/j.bbrc.2024.150770_bib26","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1021\/cb300440x","article-title":"Protein-associated cation clusters in aqueous arginine solutions and their effects on protein stability and size","volume":"8","author":"Vagenende","year":"2013","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.bbrc.2024.150770_bib27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bpc.2006.12.007","article-title":"Suppression of protein interactions by arginine: a proposed mechanism of the arginine effects","volume":"127","author":"Arakawa","year":"2007","journal-title":"Biophys. Chem."},{"key":"10.1016\/j.bbrc.2024.150770_bib28","first-page":"608","article-title":"Multi-faceted arginine: mechanism of the effects of arginine on protein, Curr. Protein Pept","volume":"15","author":"Arakawa","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.bbrc.2024.150770_bib29","doi-asserted-by":"crossref","first-page":"2925","DOI":"10.1021\/acschemneuro.4c00276","article-title":"Why is arginine the only amino acid that inhibits polyglutamine monomers from taking on toxic conformations?","volume":"15","author":"Tanimoto","year":"2024","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.bbrc.2024.150770_bib30","doi-asserted-by":"crossref","first-page":"19346","DOI":"10.1039\/D2CP02171D","article-title":"Mechanism underlying liquid-to-solid phase transition in fused in sarcoma liquid droplets","volume":"24","author":"Li","year":"2022","journal-title":"Phys. Chem. Chem. Phys."},{"key":"10.1016\/j.bbrc.2024.150770_bib31","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24043729","article-title":"The regulatory mechanism of transthyretin irreversible aggregation through liquid-to-solid phase transition","volume":"24","author":"Duan","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbrc.2024.150770_bib32","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1007\/s10545-012-9494-x","article-title":"Creatine metabolism in urea cycle defects","volume":"35","author":"Boenzi","year":"2012","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.bbrc.2024.150770_bib33","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1001\/jamaneurol.2015.5072","article-title":"Recommendations for the management of strokelike episodes in patients with mitochondrial encephalomyopathy, lactic acidosis, and strokelike episodes","volume":"73","author":"Koenig","year":"2016","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.bbrc.2024.150770_bib34","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1212\/WNL.58.5.827","article-title":"Effects of L-arginine on the acute phase of strokes in three patients with MELAS","volume":"58","author":"Koga","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.bbrc.2024.150770_bib35","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1212\/01.WNL.0000151976.60624.01","article-title":"L-arginine improves the symptoms of strokelike episodes in MELAS","volume":"64","author":"Koga","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.bbrc.2024.150770_bib36","first-page":"2723","article-title":"Amyloidosis forum meeting panelists, advancing transthyretin amyloidosis drug development in an evolving treatment landscape: amyloidosis forum meeting proceedings, adv. Ther., amyloidosis forum meeting panelists","volume":"41","author":"Maurer","year":"2024","journal-title":"Advancing transthyretin amyloidosis drug development in an evolving treatment landscape: Amyloidosis Forum"},{"key":"10.1016\/j.bbrc.2024.150770_bib37","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1080\/13506129.2022.2128331","article-title":"Distribution and progression of cerebral amyloid angiopathy in early-onset V30M (p.V50M) hereditary ATTR amyloidosis","volume":"30","author":"Takahashi","year":"2023","journal-title":"Amyloid"},{"key":"10.1016\/j.bbrc.2024.150770_bib38","doi-asserted-by":"crossref","first-page":"955","DOI":"10.3390\/genes12070955","article-title":"Ocular involvement in hereditary amyloidosis","volume":"12","author":"Minnella","year":"2021","journal-title":"Genes"},{"key":"10.1016\/j.bbrc.2024.150770_bib39","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.2174\/1570159X21666230623094710","article-title":"Does patisiran reduce ocular transthyretin synthesis? A pilot study of two cases","volume":"21","author":"Cambieri","year":"2023","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.bbrc.2024.150770_bib40","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1152\/physrev.1983.63.4.1481","article-title":"Brain metabolism: a perspective from the blood-brain barrier","volume":"63","author":"Pardridge","year":"1983","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.bbrc.2024.150770_bib41","doi-asserted-by":"crossref","first-page":"2715","DOI":"10.1007\/s11095-010-0272-x","article-title":"Lipophilicity and transporter influence on blood-retinal barrier permeability: a comparison with blood-brain barrier permeability","volume":"27","author":"Hosoya","year":"2010","journal-title":"Pharm. Res. (N. Y.)"}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X24013068?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X24013068?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,10]],"date-time":"2025-02-10T16:09:29Z","timestamp":1739203769000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X24013068"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":41,"alternative-id":["S0006291X24013068"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2024.150770","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Arginine: A potential prophylactic supplement for transthyretin amyloidosis","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2024.150770","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"150770"}}